Karl Überla

47 papers receiving 3.1k citations

Karl Überla's Hit Papers

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS 1994 · 2.9k citations
2.9k0+10+21Years since publication50010001.5k2.0k2.5k

Peers

Karl Überla
Comparison fields: 5 of 149
  • Internal Medicine 391
  • Cardiology and Cardiovascular Medicine 1.7k
  • Pharmacology 348
  • Surgery 712
  • Hematology 185
Replace M Cloarec with:
M Cloarec France
G. Arapakis Greece
Tullio DiPerri Italy
Ulf Berglund Sweden
N Pfluger Switzerland
Ruth E. Reuter Australia
J Pastéyer France
S Jonas United States
Yolande Loria France
L Gregoratti
Karl Überla relative to M Cloarec France M Cloarec's profile →
Citations per field
00.5×1.5×2×2.5×
M Cloarec · 1×
Citations per year

Countries citing papers authored by Karl Überla

Since Specialization
Citations

This map shows the geographic impact of Karl Überla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Überla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Überla more than expected).

Fields of papers citing papers by Karl Überla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Überla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Überla. The network helps show where Karl Überla may publish in the future.

Co-authors

The 25 scholars most cited alongside Karl Überla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karl Überla Line = papers co-authored together Karl Überla links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Hit paper breakdown →
19942867
2 197968
3 201563
4 196854
5 199253
6 200437
7
Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study.
198723
8 200122
9 200222
10
[STUDIES FOR THE EVALUATION OF COLLOIDAL VOLUME SUBSTITUTION].
196521
11 200319
12 200119
13
PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.
198518
14 200216
15 198711
16
Faktorenanalyse : eine systematische Einführung für Psychologen, Mediziner, Wirtschafts- und Sozialwissenschaftler
196810
17 20049
18 20028
19
Haemostasiological parameters as risk factor for new arterial occlusions in diabetics.
19867
20 19797

About Karl Überla

Karl Überla is a scholar working on General Health Professions, Cardiology and Cardiovascular Medicine, Health Information Management, Statistics and Probability and Physiology, having authored 55 papers that have together received 3.4k indexed citations. Recurring topics across this work include Health and Medical Studies (7 papers), Peripheral Artery Disease Management (4 papers), Smoking Behavior and Cessation (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Electronic Health Records Systems (3 papers), Pancreatitis Pathology and Treatment (2 papers), Prion Diseases and Protein Misfolding (2 papers) and Salmonella and Campylobacter epidemiology (2 papers). The work is most often cited by research in Internal Medicine (391 citations), Cardiology and Cardiovascular Medicine (1.7k citations), Pharmacology (348 citations), Surgery (712 citations) and Hematology (185 citations). Karl Überla has collaborated with scholars based in Germany, Netherlands and Japan. Frequent co-authors include Armin von Gunten, Sandra Schlaefke, Klaus Breddin, E. Walter, Donald E. Loew, Klaus Lechner, Rolf Weitkunat, Nicole M. Meyer, Ahnefeld Fw and Martin Dugas. Their work appears in journals such as Methods of Information in Medicine, Thrombosis and Haemostasis, Leukemia, Journal of Health Psychology and European Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact